$3,620,000 of NORTHROP GRUMMAN CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"FY25 Defense Appropriations Act (H.R. 8774; S. 4921); FY25 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (H.R. 8580; S. 4677); National Security Space Programs; Microelectronics; FY25 Servicemember Quality of Life Improvement and National Defense Authorization Act (H.R. 8070; S. 4638); Establishing the Congressional Budget for the United States Government for FY2025 and Setting Forth the Appropriate Budgetary Levels for FY2026 through FY2034 (H.Con.Res. 14); Full-Year Continuing Appropriations and Extensions Act, 2025 (H.R. 1968) FY25 Defense Appropriations Act (H.R. 8774; S. 4921); FY25 Servicemember Quality of Life Improvement and National Defense Authorization Act (H.R. 8070; S. 4638); Full-Year Continuing Appropriations and Extensions Act, 2025 (H.R. 1968); Establishing the Congressional Budget for the United States Government for Fiscal Year 2025 and Setting Forth the Appropriate Budgetary Levels for Fiscal Years 2026 through 2034 (H.Con.Res. 14) Amortization of Qualified Research and Experimentation Expenses; Additional First-year ("Bonus") Depreciation Deduction; Corporate Statutory Rate; Establishing the Congressional Budget for the United States Government for Fiscal 2025 and Setting Forth the Appropriate Budgetary Levels for Fiscal Years 2026 through 2034 (H.Con.Res. 14) Export Control Reform, Foreign Military Sales, Defense Trade, International Sales FY25 Servicemember Quality of Life Improvement and National Defense Authorization Act (H.R. 8070; S. 4638); Intelligence Authorization Act for Fiscal Year 2025 (H.R. 8512; S. 4443) Reprogrammings; Establishing the Congressional Budget for the United States Government for Fiscal Year 2025 and Setting Forth the Appropriate Budgetary Levels for Fiscal Years 2026 through 2034 (H.Con.Res. 14) FY25 Commerce, Justice, Science Appropriations Act (H.R. 9026; S. 4795); Full-Year Continuing Appropriations and Extensions Act, 2025 (H.R. 1968); NASA Transition Authorization Act of 2025 (S. 933); Orbits Act of 2023 (S. 447); Space Research and Continuing Exploration (RACE) Act (H.R. 529)"
You can find more data on corporate lobbying on Quiver Quantitative.
NOC Insider Trading Activity
NOC insiders have traded $NOC stock on the open market 64 times in the past 6 months. Of those trades, 0 have been purchases and 64 have been sales.
Here’s a breakdown of recent trading of $NOC stock by insiders over the last 6 months:
- KATHY J WARDEN (Chair, CEO and President) sold 3,750 shares for an estimated $1,783,687
- BENJAMIN R. DAVIES (CVP & Pres. Defense Systems) has made 0 purchases and 4 sales selling 2,105 shares for an estimated $1,042,725.
- MICHAEL A HARDESTY (Corp VP, Controller & CAO) sold 1,931 shares for an estimated $875,872
- KATHRYN G SIMPSON (Corp VP & General Counsel) has made 0 purchases and 2 sales selling 1,924 shares for an estimated $840,013.
- MARK A III WELSH has made 0 purchases and 56 sales selling 198 shares for an estimated $95,114.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
NOC Hedge Fund Activity
We have seen 685 institutional investors add shares of NOC stock to their portfolio, and 661 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY removed 805,949 shares (-16.2%) from their portfolio in Q4 2024, for an estimated $378,223,806
- CAPITAL INTERNATIONAL INVESTORS added 461,307 shares (+5.9%) to their portfolio in Q4 2024, for an estimated $216,486,762
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 457,927 shares (-87.5%) from their portfolio in Q4 2024, for an estimated $214,900,561
- PRICE T ROWE ASSOCIATES INC /MD/ added 450,858 shares (+28.5%) to their portfolio in Q4 2024, for an estimated $211,583,150
- BALYASNY ASSET MANAGEMENT L.P. removed 429,796 shares (-98.9%) from their portfolio in Q4 2024, for an estimated $201,698,964
- FIRST TRUST ADVISORS LP added 371,814 shares (+337.1%) to their portfolio in Q4 2024, for an estimated $174,488,592
- INVESCO LTD. added 343,018 shares (+24.7%) to their portfolio in Q4 2024, for an estimated $160,974,917
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NOC Analyst Ratings
Wall Street analysts have issued reports on $NOC in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 04/16/2025
- Wells Fargo issued a "Overweight" rating on 03/07/2025
- Susquehanna issued a "Positive" rating on 01/08/2025
To track analyst ratings and price targets for NOC, check out Quiver Quantitative's $NOC forecast page.
NOC Price Targets
Multiple analysts have issued price targets for $NOC recently. We have seen 3 analysts offer price targets for $NOC in the last 6 months, with a median target of $550.0.
Here are some recent targets:
- Charles Minervino from Susquehanna set a target price of $557.0 on 01/08/2025
- Sheila Kahyaoglu from Jefferies set a target price of $550.0 on 10/30/2024
- David Strauss from Barclays set a target price of $550.0 on 10/29/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
